Form 8-K - Current report:
SEC Accession No. 0001493152-23-031057
Filing Date
2023-08-31
Accepted
2023-08-31 16:18:56
Documents
14
Period of Report
2023-08-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 68053
2 ex99-1.htm EX-99.1 27140
  Complete submission text file 0001493152-23-031057.txt   336187

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE murf-20230831.xsd EX-101.SCH 4206
4 XBRL DEFINITION FILE murf-20230831_def.xml EX-101.DEF 27335
5 XBRL LABEL FILE murf-20230831_lab.xml EX-101.LAB 37936
6 XBRL PRESENTATION FILE murf-20230831_pre.xml EX-101.PRE 25955
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7000
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
Murphy Canyon Acquisition Corp. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 231229266
SIC: 2834 Pharmaceutical Preparations